Together, these findings indicate a distinct signature of aberrant DNA methylation in t(8;21) AML, consistent with the hypothesis that AML1‐ETO alters epigenetic patterning to drive leukaemogenesis via deregulation of specific complementary gene sets, which may be susceptible to hypomethylating agents. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.